Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Winzer Pharma is a specialized German pharmaceutical company focused on the development and distribution of ophthalmic products. Based in Berlin, the company offers a comprehensive portfolio of eye care treatments, including medications for dry eye, infections, and inflammatory conditions. Since its acquisition by Bausch + Lomb in 1992, it has operated as a key component of their European ophthalmology business. The company's product line includes well-known brands such as Vidisic, Corneregel, and Floxal, which are widely used in clinical practice. Dr. Winzer Pharma maintains a strong reputation for quality in the production of eye drops and ointments. It serves as a regional hub for Bausch + Lomb's ophthalmic operations in the DACH region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Winzer Pharma.